Price $2.45 |
Market Cap
146.7M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
4.77
|
Dividend %
-
|
|
P/CF
6.3
|
P/FCF
-
|
Op. Cash Flow
-53K
|
FCF
-2.1
|
|
Op. Margin
-485.60%
|
Net Margin
-884.60%
|
ROE
151.50%
|
ROI
385.80%
|
|
ROA
-358.50%
|
EPS Growth
15.10%
|
Current Ratio
1.6
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Daxor Corporation (DXR) | $6.81 | - | 0.40% | 26.7M | Strong Buy |
| CRYO-CELL International, Inc. (CCEL) | $5.60 | - | - | 66.9M | Strong Buy |
| iCAD Inc (ICAD) | $4.69 | - | - | 93.1M | Strong Buy |
| Community Health Systems (CYH) | $9.36 | - | - | 966.8M | Strong Buy |
| Encision Inc (ECIA) | $0.40 | - | - | 3.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
